331 related articles for article (PubMed ID: 31069541)
1. Perioperative management of patients with atrial fibrillation receiving anticoagulant therapy.
Omae T; Koh K; Kumemura M; Sakuraba S; Katsuda Y
J Anesth; 2019 Aug; 33(4):551-561. PubMed ID: 31069541
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
Hirano T; Kaneko H; Mishina S; Wang F; Morita S
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
[TBL] [Abstract][Full Text] [Related]
4. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
[TBL] [Abstract][Full Text] [Related]
5. Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Comparison With Younger Patients.
Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
JACC Clin Electrophysiol; 2018 May; 4(5):592-600. PubMed ID: 29798785
[TBL] [Abstract][Full Text] [Related]
6. Oral anticoagulant treatment in management of elderly patients with atrial fibrillation [corrected]: is it beneficial or detrimental?
Setiabudi E; Alwi I; Setiati S
Acta Med Indones; 2008 Jan; 40(1):40-7. PubMed ID: 18326899
[TBL] [Abstract][Full Text] [Related]
7. Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study).
Turagam MK; Parikh V; Afzal MR; Gopinathannair R; Lavu M; Kanmanthareddy A; Pillarisetti J; Reddy M; Atkins D; Bommana S; Jaeger M; Jeffery C; Mohanty S; Santangeli P; Cheng J; Di Biase L; Narasimhan C; Natale A; Lakkireddy D
J Cardiovasc Electrophysiol; 2017 Aug; 28(8):853-861. PubMed ID: 28497899
[TBL] [Abstract][Full Text] [Related]
8. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
9. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
[TBL] [Abstract][Full Text] [Related]
10. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM
Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
[No Abstract] [Full Text] [Related]
11. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis.
Bai Y; Guo SD; Deng H; Shantsila A; Fauchier L; Ma CS; Lip GYH
Age Ageing; 2018 Jan; 47(1):9-17. PubMed ID: 28985259
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness for prevention of thromboembolism by anticoagulants in non-valvular atrial fibrillation: additional analysis from the Hokuriku-Plus AF Registry.
Yamagishi M; Tsuda T; Kato T; Furusho H; Hayashi K;
Heart Vessels; 2019 Jun; 34(6):1024-1030. PubMed ID: 30612144
[TBL] [Abstract][Full Text] [Related]
14. Edoxaban: A direct oral anticoagulant.
Poulakos M; Walker JN; Baig U; David T
Am J Health Syst Pharm; 2017 Feb; 74(3):117-129. PubMed ID: 28122753
[TBL] [Abstract][Full Text] [Related]
15. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
[TBL] [Abstract][Full Text] [Related]
16. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians.
Douketis JD
Thromb Res; 2002 Oct; 108(1):3-13. PubMed ID: 12586125
[TBL] [Abstract][Full Text] [Related]
17. Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation.
Kido K; Ngorsuraches S
Ann Pharmacother; 2019 Feb; 53(2):165-170. PubMed ID: 30130979
[TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulant therapies: balancing the risks.
Nutescu EA
Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S3-11. PubMed ID: 23640530
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.
Brais C; Larochelle J; Turgeon MH; Blais L; Farand P; Perreault S; Letemplier G; Beauchesne MF
J Pharm Pharm Sci; 2017; 20():8-14. PubMed ID: 28459661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
